Parrish Robert M, Sitkoff Doree F, Cheney Daniel L, Sherrill C David
Center for Computational Molecular Science and Technology, School of Chemistry and Biochemistry, School of Computational Science and Engineering, Georgia Institute of Technology, Atlanta, GA, 30332-0400, USA.
Molecular Structure and Design, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, NJ, 08534, USA.
Chemistry. 2017 Jun 12;23(33):7887-7890. doi: 10.1002/chem.201701031. Epub 2017 May 23.
The study of noncovalent interactions, notably including drug-protein binding, relies heavily on the language of localized functional group contacts: hydrogen bonding, π-π interactions, CH-π contacts, halogen bonding, etc. Applying the state-of-the-art functional group symmetry-adapted perturbation theory (F-SAPT) to an important question of chloro versus methyl aryl substitution in factor Xa inhibitor drugs, we find that a localized contact model provides an incorrect picture for the origin of the enhancement of chloro-containing ligands. Instead, the enhancement is found to originate from many intermediate-range contacts distributed throughout the binding pocket, particularly including the peptide bonds in the protein backbone. The contributions from these contacts are primarily electrostatic in nature, but require ab initio computations involving nearly the full drug-protein pocket system to be accurately quantified.
对非共价相互作用的研究,尤其是包括药物与蛋白质的结合,在很大程度上依赖于局部官能团接触的描述:氢键、π-π相互作用、CH-π接触、卤键等。将最新的官能团对称适配微扰理论(F-SAPT)应用于凝血因子Xa抑制剂药物中氯取代与甲基取代这一重要问题,我们发现局部接触模型对于含氯配体增强作用的起源给出了错误的描述。相反,发现这种增强作用源于分布在整个结合口袋中的许多中程接触,特别是包括蛋白质主链中的肽键。这些接触的贡献本质上主要是静电作用,但需要涉及几乎整个药物-蛋白质口袋系统的从头计算才能准确量化。